For InvestorsAbout AuxiliumTestim®Product PipelineNews And InformationFor InvestorsFor InvestorsCareers
For Investors

2012 Annual Report | 2013 Proxy Statement

Auxilium is dedicated to keeping our investors informed about the latest corporate information. To this end, this section is designed to provide comprehensive, up-to-date, public information.

Webcast ImageWebcast
Auxilium Pharmaceuticals, Inc. at UBS Global Healthcare Conference  (Replay)
May 21, 2013 at 3:00 p.m. ET
Webcast ImageWebcast
Auxilium Pharmaceuticals, Inc. at Bank of America Merrill Lynch Health Care Conference (Replay)
May 15, 2013 at 3:00 p.m. PT
Corporate Profile
Auxilium Pharmaceuticals (NASDAQ: AUXL) was founded in 1999 to develop and market pharmaceutical products that focus on urology and sexual health. While we remain dedicated to this founding principle, Auxilium’s mission has expanded to include the development and marketing of novel treatment options for many of society’s unmet medical needs.

To support this mission of providing innovati... More >>

Stock Quote
AUXL (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Price$15.13
Change (%) Stock is Up 0.03 (0.20%)
Volume695,500
Data as of May 21, 2013 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent News
RSS Feeds RSS
|
More >>
DateTitle 
May 15, 2013Auxilium Pharmaceuticals, Inc. To Present At The UBS Global Health Care ConferencePrinter Friendly Version
May 10, 2013Auxilium Pharmaceuticals, Inc. To Present At The Bank Of America Merrill Lynch 2013 Health Care ConferencePrinter Friendly Version
Apr 29, 2013Auxilium Pharmaceuticals, Inc, Announces First Quarter 2013 Financial ResultsPrinter Friendly Version
Apr 29, 2013Auxilium Pharmaceuticals Completes Acquisition Of Actient Holdings LLC To Create A Leading Urology Franchise With A Diversified Product Portfolio And Strong Growth ProfilePrinter Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
Featured Report
There are currently no items available.
Receive E-mail AlertsE-mail Alert Icon
To recieve email alerts about updates to Auxilium Pharmaceuticals, Inc. information, please enter your email address.
 
Quotes delayed at least 15 minutes. Market data provided by Interactive Data.

Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.